Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 945.70
+11.85 (1.27%)
Nov 11, 2026, 1:00 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 185.08 billion as of November 10, 2026. Its market cap has increased by 146.31% in one year.
Market Cap
185.08B
Enterprise Value
191.24B
Revenue
18.44B
Global Rank
n/a
Country Rank
n/a
PE Ratio
69.54
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 185.08B, an increase of 410,301.76%. That is a compound annual growth rate of 35.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 185.08B | 194.62% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 330.10B |
| Piramal Pharma | 327.49B |
| Alembic Pharmaceuticals | 199.96B |
| Alivus Life Sciences | 181.01B |
| Eris Lifesciences | 174.19B |
| Cohance Lifesciences | 169.74B |
| NATCO Pharma | 157.79B |
| Sudeep Pharma | 136.70B |